Neither PRP nor stem cell therapy is universally better. The right choice depends on what you’re treating, how severe the damage is, and what you can afford. PRP works well for mild to moderate joint pain and tendon injuries at a fraction of the cost, while stem cell therapy shows stronger results for more advanced joint degeneration. Here’s how the two actually compare across the factors that matter most.
How Each Treatment Works
PRP (platelet-rich plasma) uses a concentrated dose of your own platelets, drawn from a simple blood sample. Those platelets release growth factors, including ones that stimulate blood vessel formation, cell growth, and tissue repair. When injected into a damaged area, these signals recruit your body’s existing repair cells and accelerate healing. Think of PRP as turning up the volume on your body’s natural recovery process.
Stem cell therapy takes a more direct approach. Mesenchymal stem cells, typically harvested from your bone marrow or fat tissue, can differentiate into cartilage, bone, or fat cells depending on where they’re placed. But the bigger discovery in recent years is that these cells do most of their work by releasing anti-inflammatory signals and reprogramming the local immune environment. They suppress overactive inflammation, shift immune cells toward a repair-promoting state, and secrete proteins that protect surrounding tissue. This combination of direct tissue building and immune modulation gives stem cells a broader toolkit than PRP alone.
Knee Osteoarthritis: Where the Gap Is Clearest
For knee osteoarthritis, the evidence tilts toward stem cell therapy, particularly bone marrow aspirate concentrate (BMAC). A comparative study tracking patients over 12 months found that BMAC patients improved their pain scores by 57%, their knee function scores by about 76%, and their overall joint scores by roughly 74%. PRP patients in the same study saw only modest, statistically nonsignificant improvements across all the same measures.
The difference was striking. BMAC outperformed PRP by about 52% on the standard osteoarthritis assessment scale and by 54% on knee function scores. For people with meaningful cartilage loss, this gap makes sense. PRP can reduce inflammation and support the tissue you still have, but it can’t rebuild cartilage that’s already gone. Stem cells have the potential to generate new cartilage tissue and simultaneously calm the chronic inflammation that drives osteoarthritis progression.
That said, early-stage osteoarthritis with mild symptoms may respond just fine to PRP. If you still have reasonable cartilage thickness and your primary issue is pain and swelling, PRP’s growth factors can be enough to shift the joint environment toward repair.
Tendon Injuries: PRP Holds Its Own
For tendon problems, the picture looks different. PRP has a strong track record with injuries like partial rotator cuff tears. In a study comparing PRP injections to surgical repair for high-grade partial tears, both groups reached nearly identical functional scores at two years: 95.3 for PRP and 96.5 for surgery. The PRP group achieved a 96% success rate, with only one patient eventually needing surgical intervention.
The real advantage for PRP in tendon injuries was recovery time. Patients returned to normal activity in an average of 3.3 months after PRP, compared to 4.6 months after surgery. That 1.3-month difference matters if you’re trying to get back to work or sport. Tendons have a simpler structure than joint cartilage and respond well to concentrated growth factor stimulation, which is exactly what PRP delivers. For most tendon injuries, stem cell therapy offers diminishing returns relative to its higher cost and complexity.
Cost Comparison
PRP is significantly cheaper. A single injection typically runs $500 to $2,500 out of pocket, with most patients paying around $750 per session plus an initial consultation fee. Some conditions require two or three treatments spaced weeks apart, but even a full course of PRP rarely exceeds $5,000 to $7,000.
Stem cell therapy starts where PRP’s upper range ends. Simple protocols using same-day fat tissue processing cost $5,000 to $8,000. Bone marrow extraction procedures, which require penetrating bone and more specialized equipment, range from $5,000 to $15,000 for a single joint. Complex protocols or treatments at premium clinics can reach $25,000 or more. One patient who had a bone marrow stem cell procedure on a single knee reported paying $6,500 total, which included two PRP injections ($1,500) as part of the protocol alongside the stem cell treatment ($5,000).
Neither treatment is covered by most insurance plans. You’re paying out of pocket for both, which makes the cost gap a real decision factor.
The Harvesting Experience
PRP requires only a standard blood draw. A small sample is spun in a centrifuge to concentrate the platelets, and the injection happens the same visit. The whole process takes under an hour.
Stem cell harvesting is more involved, and the experience differs depending on the source. Bone marrow aspiration involves inserting a needle into the back of your hip bone (the iliac crest) under local anesthesia. It’s an invasive procedure that can cause soreness at the harvest site for several days. The tradeoff is that bone marrow yields a higher initial concentration of certain cell types.
Fat-derived stem cells come from a mini-liposuction procedure, typically from the abdomen or thigh. This is considered less invasive than bone marrow aspiration and can be done under local anesthesia. Research shows that fat tissue starts with fewer stem cells per milliliter than bone marrow, but those cells multiply nearly four times faster once collected, which can compensate for the lower starting count. Both harvesting methods are same-day procedures when the cells aren’t being cultured or expanded in a lab.
Recovery After Injection
PRP recovery follows a predictable pattern. The first week brings mild to moderate soreness at the injection site as inflammation kicks off the healing cascade. By weeks one through four, most people notice real pain relief and better function. The remodeling phase stretches from four to twelve weeks, with significant improvement in mobility. Peak benefits typically arrive between three and six months, as tissue continues to strengthen. Most people can resume light activity within a few days of the injection itself.
Stem cell therapy recovery is similar in the early stages, with local soreness and swelling for the first week or two. However, the biological timeline is longer because stem cells need time to integrate, differentiate, and remodel tissue. Many patients report gradual improvement over three to six months, with continued gains possible up to a year. If your cells were harvested from bone marrow, expect some additional hip soreness for a few days on top of the injection-site recovery.
Regulatory Status in the U.S.
PRP is widely available and generally considered a low-risk procedure. Because it uses your own blood with minimal processing, it falls into a straightforward regulatory category.
Stem cell therapy occupies a more complicated space. Under FDA rules, cells and tissues used in treatment must be “minimally manipulated” and used for their normal function in the body (called homologous use). Autologous procedures, where your own cells are harvested, processed, and reinjected the same day, can qualify under these rules without needing separate FDA drug approval. But any process that cultures, expands, or significantly alters the cells pushes the treatment into drug territory, requiring formal FDA approval that most clinics don’t have.
This means the stem cell procedure you’re offered matters enormously. A same-day bone marrow concentrate injection into a knee joint is operating within current guidelines. A clinic offering expanded or lab-grown stem cells for the same purpose may not be. Ask any clinic whether their protocol meets the FDA’s minimal manipulation and homologous use requirements before committing.
Which One Makes Sense for You
PRP is the better starting point for tendon injuries, mild joint pain, and situations where cost is a major factor. It delivers strong results for soft tissue healing, recovers quickly, and costs a fraction of stem cell therapy. For partial rotator cuff tears, tennis elbow, and early-stage joint issues, PRP often provides all the biological stimulus your body needs.
Stem cell therapy earns its higher price tag when there’s real structural damage, particularly moderate to advanced osteoarthritis where cartilage loss is significant. The ability of stem cells to both generate new tissue and reprogram the inflammatory environment gives them an edge that PRP’s growth factors alone can’t match. If you’ve already tried PRP without sufficient relief, stem cell therapy is a logical next step before considering joint replacement.
Some clinics combine both, using PRP injections alongside or after stem cell treatment to provide ongoing growth factor support while stem cells do their deeper repair work. This layered approach is increasingly common, though it adds to the total cost.